Fawcett; John Randall

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fawcett; John Randall.The latest application filed is for "method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage".

Company Profile

0.11.7

Fawcett; John Randall - Palo Alto CA US
Fawcett; John Randall - St. Paul MN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for increasing the efficacy of an agent that directly or indirectly affects a muscarinic receptor through administration of a pyrophosphate analog Grant 9,072,756 - Frey, II , et al. July 7, 2	2015-07-07
Methods and compositions for protecting and treating muscarinic receptors by administering a pyrophosphate analog to a subject exposed to bacterial, fungal, viral, prion or algal infection Grant 8,771,681 - Frey, II , et al. July 8, 2	2014-07-08
Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ions Grant 8,772,263 - Frey, II , et al. July 8, 2	2014-07-08
Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage Grant 8,765,711 - Frey, II , et al. July 1, 2	2014-07-01
Method For Protecting And Treating At Least One Muscarinic Receptor From Dysfunction Resulting From Free Radical Damage App 20110236365 - Frey, II; William H. ; et al.	2011-09-29
Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analog Grant 7,972,595 - Frey, II , et al. July 5, 2	2011-07-05
Methods and compositions for protecting and treating muscarinic receptors through administration of at least one protective agent Grant 7,786,166 - Frey, II , et al. August 31, 2	2010-08-31
Methods and compositions for enhancing cellular function through protection of tissue components Grant 7,084,126 - Frey, II , et al. August 1, 2	2006-08-01
Methods and compositions for increasing the efficacy of an agent that directly or indirectly affects a muscarinic receptor through administration of a pyrophosphate analog App 20060030542 - Frey; William H. II ; et al.	2006-02-09
Methods and compositions for protecting and treating muscarinic receptors by administering a pyrophosphate analog to a subject exposed to bacterial, fungal, viral, prion or algal infection App 20060014716 - Frey; William H. II ; et al.	2006-01-19
Methods and compositions for protecting and treating muscarinic receptors through administration of at least one protective agent App 20060009414 - Frey; William H. II ; et al.	2006-01-12
Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ions App 20060009413 - Frey; William H. II ; et al.	2006-01-12
Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analog App 20050272642 - Frey, William H. II ; et al.	2005-12-08
Methods and compositions for enhancing cellular function through protection of tissue components App 20020028786 - Frey, William H. II ; et al.	2002-03-07

Company Registrations

SEC

0001564384

Fawcett John Randall

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.